Inducible nitric oxide synthase: from cloning to therapeutic applications.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 11960209.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Elucidation of the many roles of nitric oxide (NO) in homeostasis and disease states has uncovered many areas where manipulation of NO production would be of therapeutic benefit. Recent advances in gene transfer technology and the cloning of the inducible nitric oxide synthase (iNOS) gene have led to the development of strategies for gene therapy to increase NO production for the treatment of disorders ranging from vascular restenosis to impaired wound healing. This review summarizes the current status of iNOS gene therapy research.
Medical subject headings
- Genetic Therapy
- Nitric Oxide
- Nitric Oxide Synthase